Search Results

The A.R.C. Laser Fox Laser System is indicated for retinal and pan retinal photocoagulation, endophotocoagulation and transcleral cyclophotocoagulation for the treatment of: Diabetic Retinopathy Retinal tears and detachment Age related macular degeneration Retinopathy of prematurity Primary open angle glaucoma Refractory glaucoma

Not Found

The provided text is an FDA 510(k) clearance letter for the A.R.C. Laser Fox Laser System and Accessories. It states that the device is substantially equivalent to legally marketed predicate devices. However, this document does not contain any information about acceptance criteria, device performance studies, sample sizes, ground truth establishment, or any of the detailed study parameters requested in your prompt.

The letter primarily focuses on:

• Confirming the device's substantial equivalence to a predicate.
• Listing the regulation number, regulation name, and product code.
• Indicating the general controls provisions of the Act that apply.
• Providing contact information for device-related inquiries.
• Listing the "Indications For Use" for the device, which describes the medical conditions it is intended to treat.

Therefore, I cannot fulfill your request using the provided text. To answer your questions, I would need a clinical study report, a summary of safety and effectiveness data, or a detailed technical submission for the device that outlines its performance evaluation.

Ask a specific question about this device